Geneos Wealth Management Inc. Ultragenyx Pharmaceutical Inc. Transaction History
Geneos Wealth Management Inc.
- $3.92 Billion
- Q2 2025
A detailed history of Geneos Wealth Management Inc. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 27 shares of RARE stock, worth $855. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27
Previous 60
55.0%
Holding current value
$855
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RARE
# of Institutions
365Shares Held
88.1MCall Options Held
3.64MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA10.2MShares$324 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$178 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$125 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$91.5 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY2.77MShares$87.9 Million1.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.22B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...